Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study further evaluates the safety profile and efficacy of the Ellipse IM HTO Nail system in subjects with osteoarthritis and varus malalignment of the knee. All subjects will receive treatment with the Ellipse IM HTO Nail System and followed for six months.
The Ellipse IM HTO Nail is intended for open wedge proximal tibial osteotomies. The Ellipse IM HTO Nail is an intramedullary nail that operates on the principles of distraction osteogenesis.
The Ellipse IM HTO Nail is used in valgizing HTO procedures to correct varus malalignment. The Ellipse IM HTO Nail is surgically placed in the intramedullary canal of the tibia. It is lengthened telescopically using the non-invasive external remote control.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| IM HTO Nail | Implant with the Ellipse IM HTO Nail |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Ellipse IM HTO Nail | Device |
|
| Measure | Description | Time Frame |
|---|---|---|
| Weight-Bearing Line at Final Correction within Âħ5, 10, and 15% of Baseline Target | Pre-Op, Week 6 (Considered the Final Correction Visit unless additional visits are required) |
| Measure | Description | Time Frame |
|---|---|---|
| Absolute Difference in Weight-Bearing Line Final Target versus Actual at Final Consolidation | Week 6 (Considered the Final Correction Visit unless additional visits are required), Month 6 (Considered the Final Consolidation Visit unless additional visits are required) | |
| Absolute Difference in Weight-Bearing Line Baseline Target versus Final Target |
| Measure | Description | Time Frame |
|---|---|---|
| Serious Adverse Events | Incidence of Serious Adverse Events upon enrollment into the study | Pre-Op, Operative, Week 2, Week 4, Week 6, Month 3, Month 6 |
| Unanticipated Adverse Device Effects | Incidence of Unanticipated Adverse Effects upon enrollment into the study |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Subjects who meet the protocol eligibility criteria including standing varus malalignment in the limb presenting with osteoarthritis of the knee.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Mark T Dahl, MD | University of Minnesota | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Medizinische Hochschule | Hanover | Germany | ||||
| Martini Ziekenhuis |
Not provided
| ID | Term |
|---|---|
| D010003 | Osteoarthritis |
| ID | Term |
|---|---|
| D001168 | Arthritis |
| D007592 | Joint Diseases |
| D009140 | Musculoskeletal Diseases |
| D012216 | Rheumatic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Baseline Target versus Final Target |
| Pre-Op, Month 6 (Considered the Final Consolidation Visit unless additional visits are required) |
| Change in Hip-Knee-Ankle Angle Baseline versus Final Correction | Baseline versus Final Correction | Pre-Op, Week 6 (Considered the Final Correction Visit unless additional visits are required) |
| Change in Hip-Knee-Ankle Angle Baseline versus Final Consolidation | Pre-Op, Month 6 (Considered the Final Consolidation Visit unless additional visits are required) |
| Change in Tibial Slope Angle Baseline versus Final Correction | Baseline versus Final Correction | Pre-Op, Week 6 (Considered the Final Correction Visit unless additional visits are required) |
| Change in Tibial Slope Angle Baseline versus Final Consolidation | Baseline versus Final Consolidation | Pre-Op, Month 6 (Considered the Final Consolidation Visit unless additional visits are required) |
| Time to Full Weight-Bearing | Amount of time required until a patient is allowed to put 100% of their body weight on the leg. | Week 2, Week 4, Week 6, Month 3, Month 6 |
| Pre-Op, Operative, Week 2, Week 4, Week 6, Month 3, Month 6 |
| Non-Serious Adverse Events | Incidence of Non-Serious Adverse Events upon enrollment into the study | Pre-Op, Operative, Week 2, Week 4, Week 6, Month 3, Month 6 |
| Secondary Surgical Procedures | Incidence of Secondary Surgical Procedures upon enrollment into the study | Pre-Op, Operative, Week 2, Week 4, Week 6, Month 3, Month 6 |
| Groningen |
| 9728 |
| Netherlands |
| Isala Klinieken | Zwolle | 8025 | Netherlands |
| Centrum Ortopedii I Traumatologii | Bialystok | Poland |
| Zagiel Hospital | Lublin | Poland |
| Lekmed Hospital | Warsaw | 01-480 | Poland |
| District Hospital of Wolomin | WoĊomin | Poland |
| North Bristol NHS Trust | Bristol | BS10 5NB | United Kingdom |
| North Cumbria University Hospital | Carlisle | CA2 7HY | United Kingdom |
| University Hospital Aintree | Liverpool | L9 7AL | United Kingdom |
| University Hospitals Southampton | Southampton | SO16 6YD | United Kingdom |